Glutamine metabolism-related genes predict the prognostic risk of acute myeloid leukemia and stratify patients by subtype analysis
Abstract Background Acute myeloid leukemia (AML) is a genetically heterogeneous disease in which glutamine (Gln) contributes to AML progression.Therefore, this study aimed to identify potential prognostic biomarkers for AML based on Gln metabolism-related genes.Methods Gln-related genes that were Baby Tee differentially expressed between Cancer Gen